Cramer says Vertex has a drug that may address the ‘largest market opportunity in the world'

  • 📰 NBCNewYork
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 63%

France Nouvelles Nouvelles

France Dernières Nouvelles,France Actualités

CNBC’s Jim Cramer said investors keep an eye on Vertex Pharmaceuticals (VRTX) as the company develops a non-opioid pain drug.

"The biggest pharmacy issue how do we get pain removed, or at least nullified, without opiates? They have a plan — Vertex," Cramer said onunderway for the pain drug, known as VX-548. Vertex has said its goal is to create a new class of prescription medications that relieve pain and address the shortcomings of opioids, namely their addictive potential.

"I do believe that if they have something, it would be the largest market opportunity in the world," Cramer said, adding that late-stage study results for VX-548 are expected"within the year."In a note to clients Monday, analysts at Leerink Partners argued that the investment community significantly underappreciates" the potential for VX-548.

San Francisco quarterback Brock Purdy makes nearly $1 million a year — but splits rent with a roommate and drives a Toyota SUV31-year-old teacher quit her job. Now she works at Costco—and boosted her income by 50%: ‘I've never been happier'

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 270. in FR
 

Merci pour votre commentaire. Votre commentaire sera publié après examen.

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Jim Cramer's top 10 things to watch in the stock market MondayThe Dow, S&P 500 and Nasdaq were lower Monday after Hamas conducted a surprise attack on Israel.
La source: CNBC - 🏆 12. / 72 Lire la suite »